Loading...

Categories

10 Thailand Hyperglycemics Reports

Asia Pacific SGLT2 Inhibitors Market

Country Covered: Thailand

Study Period: 2018 - 2029

Major Players: Eli Lilly, Boehringer Ingelheim, Janssen Pharmaceuticals, AstraZeneca, Bristol Myers Squibb

APAC Biguanide Industry

Country Covered: Thailand

Study Period: 2019 - 2029

Major Players: Takeda, Bristol-Myers Squibb, Glenmark, Merck and Co., Sanofi Aventis

APAC Insulin Market

Country Covered: Thailand

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Eli Lilly, Sanofi, Biocon, Gan & Lee

APAC Meglitinide Industry

Country Covered: Thailand

Study Period: 2018 - 2029

Major Players: Novo Nordisk, Glenmark, Novartis, Kissei, Biocon

Meglitinides Market

Country Covered: Thailand

Study Period: 2019- 2029

Major Players: Glenmark Pharmaceuticals, Novartis, Kissei Pharmaceuticals, Biocon, Novo Nordisk A/S

SGLT2 Inhibitors Market

Country Covered: Thailand

Study Period: 2019 - 2029

Major Players: Janssen Pharmaceuticals, Eli Lilly, Bristol Myers Squibb, AstraZeneca Pharmaceuticals, Astellas

Glargine Insulin Market

Country Covered: Thailand

Study Period: 2018 - 2029

Major Players: Sanofi Aventis, Novo Nordisk AS, Biocon, Eli Lilly and Company, Julphar

Basal Insulin (Long-Acting Insulin) Market

Country Covered: Thailand

Study Period: 2019 - 2029

Major Players: Novo Nordisk, Sanofi, Eli Lilly, Biocon, Wockhardt

Sulfonylureas Industry

Country Covered: Thailand

Study Period: 2019- 2029

Major Players: Sanofi Aventis, Pfizer Inc., Merck & Co., Inc., Torrent Pharma, Dr. Reddy's Laboratories

Biguanides Market

Country Covered: Thailand

Study Period: 2018 - 2029

Major Players: Bristol Myers Squibb, Glenmark Pharmaceuticals, Takeda, Sanofi Aventis, Merck and Co.